Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 May-Jun;15(3):91-97.
doi: 10.4103/ijt.ijt_70_23. Epub 2023 Dec 1.

Low-dose Oral Minoxidil in the Treatment of Alopecia: Evidence and Experience-based Consensus Statement of Indian Experts

Affiliations
Review

Low-dose Oral Minoxidil in the Treatment of Alopecia: Evidence and Experience-based Consensus Statement of Indian Experts

Kiran Godse et al. Int J Trichology. 2023 May-Jun.

Abstract

Alopecia is a highly prevalent condition worldwide including in India. There are different types of alopecia with differing etiology, presentation, and hence treatment. Androgenetic alopecia represents the most common form of hair loss affecting male as well as female population termed as male and female pattern hair loss, respectively. Several treatment options are available for the treatment of alopecia with often unsatisfactory results resulting in psychological distress among such patients. Topical minoxidil is known to be effective in the treatment of alopecia. However, oral minoxidil is not currently approved for the treatment of alopecia. This expert consensus is prepared to provide guidance to the clinicians regarding the use of oral minoxidil in the treatment of alopecia. Extensive literature review was performed to prepare the draft consensus which was then revised based on the suggestions and comments from the experts. The final draft was circulated to the experts for review and approval. This consensus document provides overview of evidence related to oral minoxidil and consensus from the experts for its use in the treatment of minoxidil.

Keywords: Alopecia; efficacy; female pattern hair loss; male pattern hair loss; minoxidil; tolerability.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Structure of minoxidil

References

    1. Chen S, Xie X, Zhang G, Zhang Y. Comorbidities in androgenetic alopecia:A comprehensive review. Dermatol Ther (Heidelb) 2022;12:2233–47. - PMC - PubMed
    1. Mysore V, Parthasaradhi A, Kharkar RD, Ghoshal AK, Ganjoo A, Ravichandran G, et al. Expert consensus on the management of androgenetic alopecia in India. Int J Trichology. 2019;11:101–6. - PMC - PubMed
    1. Krupa Shankar D, Chakravarthi M, Shilpakar R. Male androgenetic alopecia:Population-based study in 1,005 subjects. Int J Trichology. 2009;1:131–3. - PMC - PubMed
    1. Waghel RC, Waitzman JA. Shedding light on female alopecia. US Pharm. 2013;88:62–5.
    1. Scharman EJ. 2nd ed. USA: Elsevier; 2005. Encyclopedia of Toxicology; pp. 114–5.